This Lollipop Could Help Blind Women Independently Detect Pregnancy

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-10-06T18:33:29.471Z • Permanent link

Sneha Rao, a design student from the University of California, Los Angeles, is revolutionizing the way blind women detect pregnancy. Her innovative edible pregnancy test, dubbed Tact, is set to disrupt the traditional pregnancy testing landscape. This breakthrough technology allows users to feel the results on their tongues, providing an alternative solution for individuals with vision impairment. Rao's creation is the result of months of research and development, and her ultimate goal is to empower women worldwide to take control of their reproductive health.

Tact's unique design involves an edible, sugar-based gel that changes color and texture in response to the presence of human chorionic gonadotropin (hCG). This hormone is produced by the placenta during pregnancy, and its detection is the key to confirming a positive pregnancy result. By incorporating this technology into a lollipop, Rao has created a user-friendly and accessible solution for women who face barriers in traditional pregnancy testing. The FDA has already granted Rao's prototype a Class II medical device designation, paving the way for commercialization.

Rao's journey began in 2018, when she was inspired by her own experiences as a blind woman. She realized that traditional pregnancy testing methods often left her feeling anxious and uncertain, and she set out to create a solution that would alleviate these feelings. After months of prototyping and testing, Tact was born. Rao's creation has already garnered significant attention from the medical community, with several research institutions and pharmaceutical companies expressing interest in collaborating with her.

Tact's impact on the data sources domain extends far beyond its innovative design. The product has the potential to disrupt the $13 billion pregnancy testing market, which is dominated by traditional methods such as urine tests and blood tests. Companies like First Response and E.P.T. are already facing increased competition from at-home testing kits, and Tact's edible design could further erode market share. Research institutions and pharmaceutical companies are also taking notice, as Tact's technology could pave the way for new treatments and therapies for reproductive health disorders.

The implications of Tact's success extend beyond the medical industry, too. As a pioneer in accessible reproductive health technology, Rao is helping to pave the way for a more inclusive and equitable healthcare system. By providing women with more options for testing and diagnosis, Tact is empowering them to take control of their reproductive health and make informed decisions about their bodies. This has the potential to improve health outcomes, reduce disparities, and promote greater reproductive autonomy.

Tact's development is not an isolated incident, but rather part of a larger trend towards innovation in reproductive health technology. The rise of at-home testing kits and telemedicine platforms has transformed the way we approach reproductive health, and Tact is poised to capitalize on this trend. Other companies, such as Bloom Health and Athenahealth, are already exploring new technologies and approaches to improve reproductive health outcomes.